Pharvaris所有资讯

Pharvaris | SC 13G/A：超过5%持股股东披露文件(修正)-Venrock Healthcare Capital Partners III, L.P.(6.5%),VHCP Co-Investment Holdings III, LLC(6.5%)等

02/14 20:48 (美东)

Pharvaris | SC 13G/A：超过5%持股股东披露文件(修正)-Viking Global Investors LP(7.0%),Viking Global Opportunities Parent GP LLC(7.0%)等

02/14 10:31 (美东)

Pharvaris | SC 13G/A：超过5%持股股东披露文件(修正)-Foresite Capital Fund IV, L.P. (“FCF IV”)(7.8%),Foresite Capital Management IV, LLC (“FCM IV”)(7.8%)等

02/13 14:20 (美东)

Pharvaris | SC 13G/A：超过5%持股股东披露文件(修正)-General Atlantic, L.P.(14.1%),General Atlantic PH B.V.(14.1%)等

02/13 10:15 (美东)

Pharvaris | SC 13G/A：超过5%持股股东披露文件(修正)-FMR LLC(9.989%),Abigail P. Johnson(9.989%)

02/09 09:35 (美东)

Pharvaris | SC 13G/A：超过5%持股股东披露文件(修正)-LSP V Coöperatieve U.A.(6.8%),LSP V Management B.V.(6.8%)

02/08 16:23 (美东)

Pharvaris | SC 13D/A：超过5%持股股东披露文件(修正)-Corey Goodman(8.4%),Robert Adelman(8.4%)等

01/25 14:26 (美东)

Pharvaris | SC 13G/A：超过5%持股股东披露文件(修正)-Bain Capital Life Sciences Fund, L.P.(3.8%),Bain Capital Life Sciences Opportunities III, LP(2.3%)等

01/22 00:00 (美东)

Pharvaris | SC 13G：超过5%持股股东披露文件-Venrock Healthcare Capital Partners III, L.P.(6.1%),VHCP Co-Investment Holdings III, LLC(6.1%)等

2023/11/30 16:15 (美东)

Pharvaris | SC 13G/A：超过5%持股股东披露文件(修正)-Bain Capital Life Sciences Fund, L.P.(7.1%),Bain Capital Life Sciences Opportunities III, LP(4.1%)等

2023/06/23 16:34 (美东)

Pharvaris | SC 13G/A：超过5%持股股东披露文件(修正)-General Atlantic, L.P.(10.8%),General Atlantic PH B.V.(10.8%)等

2023/06/23 15:07 (美东)

Pharvaris | SC 13D/A：超过5%持股股东披露文件(修正)-venBio Global Strategic Fund III, L.P.(10.4%),venBio Global Strategic GP III, L.P.(10.4%)等

2023/06/21 16:33 (美东)

Pharvaris | SC 13G/A：超过5%持股股东披露文件(修正)-Viking Global Investors LP(9.7%),Viking Global Opportunities Parent GP LLC(9.7%)等

2023/02/14 13:18 (美东)

Pharvaris | SC 13G/A：超过5%持股股东披露文件(修正)-James Tananbaum (“Tananbaum”)(9.7%),Foresite Capital Fund IV, L.P. (“FCF IV”)(9.6%)等

2023/02/13 16:56 (美东)

Pharvaris | SC 13G/A：超过5%持股股东披露文件(修正)-FMR LLC(9.999%),Abigail P. Johnson(9.999%)

2023/02/09 12:01 (美东)

Pharvaris | SC 13D/A：超过5%持股股东披露文件(修正)-venBio Global Strategic Fund III, L.P.(6.9%),venBio Global Strategic GP III, L.P.(6.9%)等

2022/09/26 16:24 (美东)

Pharvaris | SC 13G/A：超过5%持股股东披露文件(修正)-Viking Global Investors LP(7.4%),Viking Global Opportunities Parent GP LLC(7.4%)等

2022/02/14 17:01 (美东)

Pharvaris | SC 13G/A：超过5%持股股东披露文件(修正)-James Tananbaum (“Tananbaum”)(9.9%),Foresite Capital Fund IV, L.P. (“FCF IV”)(9.8%)等

2022/02/11 15:12 (美东)

Pharvaris | SC 13G：超过5%持股股东披露文件

2022/02/09 10:24 (美东)

Pharvaris | SC 13G：超过5%持股股东披露文件-LSP V Coöperatieve U.A.(10.9%),LSP V Management B.V.(10.9%)

2022/02/03 16:18 (美东)